Paricalcitol (chemically it is 19-nor-1,25-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. It is an analog of 1,25-dihydroxyergocalciferol, the active f...
Found on
http://en.wikipedia.org/wiki/Paricalcitol
A substance that is being used to treat overactive parathyroid glands in patients with kidney failure. It is also being studied in the treatment of cancer. Paricalcitol belongs to the family of drugs called vitamin D analogs.
Found on
http://www.cancer.gov/dictionary?expand=P
(par″ĭ-kal´sĭ-tol) a synthetic analogue of vitamin D, used for prevention and treatment of hyperparathyroidism secondary to chronic renal failure; administered intravenously.
Found on
http://www.encyclo.co.uk/local/21001
Paricalcitol: A vitamin D analogue. Brand name: Zemplar. In 1998 paricalcitol was approved by the FDA for the treatment of hyperparathyroidism due to chronic renal failure. It causes less elevation of calcium than calcitriol, another vitamin D analogue and is associated with a lower mortality rate than calcitriol in patients on long-term dialysis.
Found on
http://www.medterms.com/script/main/art.asp?articlekey=23920
No exact match found.
